- Home
- Publications
- Publication Search
- Publication Details
Title
Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer
Authors
Keywords
-
Journal
Biomolecules
Volume 9, Issue 12, Pages 789
Publisher
MDPI AG
Online
2019-11-27
DOI
10.3390/biom9120789
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk factors for distant Metastasis of patients with primary Triple Negative Breast Cancer
- (2019) Yi Yao et al. BIOSCIENCE REPORTS
- The role of dietary phytochemicals in the carcinogenesis via the modulation of miRNA expression
- (2019) Marek Samec et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Interaction of tumor-associated macrophages and cancer chemotherapy
- (2019) Irina Larionova et al. OncoImmunology
- Aurora kinase A stabilizes FOXM1 to enhance paclitaxel resistance in triple‐negative breast cancer
- (2019) Na Yang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Paclitaxel-Loaded Folate-Coated pH-Sensitive Liposomes Enhance Cellular Uptake and Antitumor Activity
- (2019) Liziane O. F. Monteiro et al. MOLECULAR PHARMACEUTICS
- Effects of miR-107 on the Chemo-drug sensitivity of breast cancer cells
- (2019) Yong Luo et al. Open Medicine
- HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation
- (2019) Tao Duan et al. BIOMEDICINE & PHARMACOTHERAPY
- A chemotherapeutic self-sensibilized drug carrier delivering paclitaxel for the enhanced chemotherapy to human breast MDA-MB-231 cells
- (2019) Lingli Zhang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling
- (2019) Dattatrya Shetti et al. Cells
- Construction and in vitro and in vivo evaluation of folic acid-modified nanostructured lipid carriers loaded with paclitaxel and chlorin e6
- (2019) Qibo Zhang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Magnetic Janus particles as a multifunctional drug delivery system for paclitaxel in efficient cancer treatment
- (2019) Zhang-Qi Feng et al. Materials Science & Engineering C-Materials for Biological Applications
- Triple negative breast cancer: new therapeutic approaches and BRCA status
- (2018) Gamze Guney Eskiler et al. APMIS
- Chemotherapeutic agents for the treatment of metastatic breast cancer: An update
- (2018) Mariam Abotaleb et al. BIOMEDICINE & PHARMACOTHERAPY
- Anthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review
- (2018) Sakshi Jasra et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- miRNA in a multiomic context for diagnosis, treatment monitoring and personalized management of metastatic breast cancer
- (2018) Pavol Zubor et al. Future Oncology
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cells
- (2018) Gabriela Nestal de Moraes et al. Oncogenesis
- Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis
- (2018) Reshma L Mahtani et al. Cancer Management and Research
- Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer—The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial
- (2018) Luca Gianni et al. JAMA Oncology
- Recent Advances in the Treatment of Breast Cancer
- (2018) Christy W. S. Tong et al. Frontiers in Oncology
- Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner
- (2018) Carlos W Wanderley et al. CANCER RESEARCH
- Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells
- (2018) Pallabita Chowdhury et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Downregulation of miR‑200c‑3p contributes to the resistance of breast cancer cells to paclitaxel by targeting SOX2
- (2018) Junqing Chen et al. ONCOLOGY REPORTS
- Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol
- (2018) Faezeh Asghari et al. Advances in Clinical and Experimental Medicine
- Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial
- (2018) Yannan Zhao et al. BMC CANCER
- Design and synthesis of mixed micellar system for enhanced anticancer efficacy of Paclitaxel through its co-delivery with Naringin
- (2018) Tooba Jabri et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Sulforaphane metabolites reduce resistance to paclitaxel via microtubule disruption
- (2018) Yalin Wang et al. Cell Death & Disease
- Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
- (2018) Luca Falzone et al. Frontiers in Pharmacology
- Folate receptor targeted delivery of paclitaxel to breast cancer cells via folic acid conjugated graphene oxide grafted methyl acrylate nanocarrier
- (2018) Kandasamy Vinothini et al. BIOMEDICINE & PHARMACOTHERAPY
- Protein Kinase Targets in Breast Cancer
- (2017) Marilina García-Aranda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epothilone B-based 3-in-1 polymeric micelle for anticancer drug therapy
- (2017) Dae Hwan Shin et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Neoadjuvant Therapy with Weekly Nanoparticle Albumin‐Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011‐02), a Multicenter, Non‐Randomized, Phase II Trial, with a Companion Biomarker Analysis
- (2017) Miguel Martín et al. ONCOLOGIST
- Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin
- (2017) Fang Shen et al. ONCOLOGY REPORTS
- Claudin-Low Breast Cancer; Clinical & Pathological Characteristics
- (2017) Kay Dias et al. PLoS One
- A multifunctional lipid nanoparticle for co-delivery of paclitaxel and curcumin for targeted delivery and enhanced cytotoxicity in multidrug resistant breast cancer cells
- (2017) Jong-Suep Baek et al. Oncotarget
- Integration of phytochemicals and phytotherapy into cancer precision medicine
- (2017) Thomas Efferth et al. Oncotarget
- Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
- (2017) Xiaofeng Dai et al. Journal of Cancer
- Role of Colloidal Drug Delivery Carriers in Taxane-mediated Chemotherapy: A Review
- (2016) Pramod Kumar et al. CURRENT PHARMACEUTICAL DESIGN
- Genetics of triple-negative breast cancer: Implications for patient care
- (2016) Anosheh Afghahi et al. CURRENT PROBLEMS IN CANCER
- A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line
- (2016) Annette Lasham et al. INTERNATIONAL JOURNAL OF CANCER
- Disparate Response to Methotrexate in Stem Versus Non-Stem Cells
- (2016) Olivia S. Beane et al. Stem Cell Reviews and Reports
- Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters
- (2016) Vlasta Němcová-Fürstová et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple negative breast cancer
- (2016) Anjie Zhu et al. Oncotarget
- Blood-based DNA methylation as biomarker for breast cancer: a systematic review
- (2016) Qiuqiong Tang et al. Clinical Epigenetics
- Disparate Response to Methotrexate in Stem Versus Non-Stem Cells
- (2016) Olivia S. Beane et al. Stem Cell Reviews and Reports
- Antimitotic drugs in the treatment of cancer
- (2015) Rustelle Janse van Vuuren et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Nanoparticle albumin-bound-paclitaxel: a limited improvement under the current therapeutic paradigm of pancreatic cancer
- (2015) Robert M Hoffman et al. EXPERT OPINION ON PHARMACOTHERAPY
- Decrease of Let-7f in Low-Dose Metronomic Paclitaxel Chemotherapy Contributed to Upregulation of Thrombospondin-1 in Breast Cancer
- (2015) Wei-Yang Tao et al. International Journal of Biological Sciences
- Cytokines as Mediators of Pain-Related Process in Breast Cancer
- (2015) Carolina Panis et al. MEDIATORS OF INFLAMMATION
- Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics
- (2015) A. Goodspeed et al. MOLECULAR CANCER RESEARCH
- Sequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cells
- (2015) Sreeja Narayanan et al. Nanomedicine-Nanotechnology Biology and Medicine
- Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
- (2015) Sara M. Tolaney et al. NEW ENGLAND JOURNAL OF MEDICINE
- Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance
- (2015) P Khongkow et al. ONCOGENE
- Triple Negative Breast Cancer
- (2014) Idil Cetin et al. Asian Pacific Journal of Cancer Prevention
- Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells
- (2014) Harris Wang et al. BMC CANCER
- Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer
- (2014) W. Si et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer
- (2014) Christine Megerdichian et al. CANCER TREATMENT REVIEWS
- Paclitaxel Induces Apoptosis in Breast Cancer Cells through Different Calcium—Regulating Mechanisms Depending on External Calcium Conditions
- (2014) Zhi Pan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Albumin-Bound Paclitaxel: The Benefit of This New Formulation in the Treatment of Various Cancers
- (2014) M. Montana et al. JOURNAL OF CHEMOTHERAPY
- How Taxol/paclitaxel kills cancer cells
- (2014) Beth A. Weaver MOLECULAR BIOLOGY OF THE CELL
- SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients
- (2014) Neil Desai et al. Translational Oncology
- Doxorubicin, DNA torsion, and chromatin dynamics
- (2013) Fan Yang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Taxane benefit in breast cancer—a role for grade and chromosomal stability
- (2013) Roger P. A'Hern et al. Nature Reviews Clinical Oncology
- Lin28 Mediates Paclitaxel Resistance by Modulating p21, Rb and Let-7a miRNA in Breast Cancer Cells
- (2012) Kezhen Lv et al. PLoS One
- Differences in autophagy-related activity by molecular subtype in triple-negative breast cancer
- (2012) Sewha Kim et al. TUMOR BIOLOGY
- Endocrine Therapy of Breast Cancer
- (2011) F. Lumachi et al. CURRENT MEDICINAL CHEMISTRY
- Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval
- (2011) Yutaka Yamamoto et al. OncoTargets and Therapy
- Differential effects of Paclitaxel on dendritic cell function
- (2010) Justin John et al. BMC IMMUNOLOGY
- Introduction to Cancer Chemotherapeutics
- (2009) Donna S. Shewach et al. CHEMICAL REVIEWS
- Paclitaxel and immune system
- (2009) Aqeel Javeed et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery
- (2009) Jessica Kao et al. PLoS One
- Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane(R)) in combination with gemcitabine in patients with metastatic breast cancer (N0531)
- (2008) V. Roy et al. ANNALS OF ONCOLOGY
- Non-anti-mitotic concentrations of taxol reduce breast cancer cell invasiveness
- (2008) Truong-An Tran et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecular basis for the development of novel taxanes in the treatment of metastatic breast cancer
- (2008) Matti S. Aapro et al. EJC SUPPLEMENTS
- Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
- (2008) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Taxanes, microtubules and chemoresistant breast cancer
- (2007) Barbara T. McGrogan et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now